MedPath

广东稳健药业有限公司

Ownership
-
Established
1998-05-22
Employees
-
Market Cap
-
Website
wenjianpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Levodopa and Benserazide Hydrochloride Tablets

Product Name
多巴丝肼片
Approval Number
国药准字H20254055
Approval Date
Apr 30, 2025
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20249688
Approval Date
Dec 6, 2024
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20249687
Approval Date
Dec 6, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.